Table 2.

Laboratory findings among patients infected with SARS-CoV-2 admitted to two hospitals in Uganda

Characteristic	All	Mulago National Specialised Hospital/−HCQ	Entebbe Regional Referral Hospital/+HCQ	P value
Laboratory
White cell count/mm3	n=47	n=21	n=26
Median (IQR)	5.1 (4.2−6.2)	5.0 (4.2−6.3)	5.1 (4.5−6.1)	0.473*
Distribution, n (%)
≥10 000/mm3	0 (0.0)	0 (0.0)	0 (0.0)
4001−<10 000/mm3	42 (89.4)	17 (81.0)	25 (92.1)	0.158†
≤4000/mm3	5 (10.6)	4 (19.0)	1 (3.9)
Neutrophil count	n=45	n=19	n=26
Median (IQR)/mm3	2 (2−2)	2 (1−2)	2 (2−2)	0.092*
Distribution, n (%)
≤1500/mm3	7 (15.6)	5 (26.3)	2 (7.7)	0.114†
Lymphocyte count	n=45	n=19	n=26
Median (IQR)/mm3	2.3 (1.8−2.9)	2.4 (1.4−2.9)	2.3 (2.0−2.9)	0.340*
Distribution, n (%)
≤1500/mm3	5 (11.1)	5 (26.3)	0 (0.0)	0.010†
Platelets per mm3	n=19	n=18	n=1
Median (IQR)	227 (121−275)	224.5 (121−275)	232	0.855*
Distribution, n (%)
<150 000/mm3	5 (26.3)	5 (27.8)	0 (0.0)	>0.999†
Haemoglobin (g/L)	n=19	n=18	n=1
Median (IQR)	1.47 (1.34−1.60)	1.47 (1.34−1.57)	1.62	0.273*
Distribution, n (%)
≤1.0 g/L	2 (10.5)	2 (11.1)	0 (0.0)	>0.999†
Aspartate aminotransferase >40 U/L, n/N (%)	4/47 (8.5)	3/18 (16.7)	1/29 (3.5)	0.150†
Alanine aminotransferase >40 U/L, n/N (%)	6/47 (12.8)	5/18 (27.8)	1/29 (3.5)	0.025†
LDH≥250 U/L, n/N (%) lactate	0/11 (0.0)	0/11 (0.0)
Creatinine ≥133 μmol/L, n/N (%)	0/48 (0.0)	0/19 (0.0)	0/29 (0.0)	–
Troponin, median (IQR)	0.1 (0.1–0.1)	0.1 (0.1–0.1)	0.1 (0.1–0.1)	0.532*
Total bilirubin >17.1 μmol/L, n/N (%)	2/15 (13.3)	2/14 (14.3)	0/1 (0.0)	>0.999†
Total bilirubin, median (IQR)	2.5 (0–12.9)	2.4 (0–11.7)	13.8	0.232*
C reactive protein ≥10 mg/L, n/N (%)	6/49 (12.2)	5/24 (20.8)	1/25 (4.0)	0.098†
Median (IQR)	1.7 (0.5–8.1)	4.0 (1.8–9.7)	0.5 (0.5–1.4)	<0.001*
Procalcitonin ng/mL	n=49	n=24	n=25
Median (IQR)	0.1 (0.1–0.12)	0.1 (0.1–0.12)	0.1 (0.1–0.13)	0.614*
Lactate dehydrogenase	n=49	n=24	n=25
Median (IQR)	330 (287–402)	318 (244–385)	330.5 (295.5–402.5)	0.282†

*Wilcoxon rank-sum test.

†Fisher’s exact test.

LDH, lactate dehydrogenase.